HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Éva Szökő Selected Research

N'-(2-phenylallyl)hydrazine

6/2013Lack of association between VAP-1/SSAO activity and corneal neovascularization in a rabbit model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Éva Szökő Research Topics

Disease

4Insulin Resistance
06/2021 - 04/2015
3Obesity
05/2022 - 04/2015
3Inflammation (Inflammations)
07/2021 - 04/2015
2Pain (Aches)
10/2021 - 03/2021
2Neuroblastoma
10/2020 - 08/2020
2Parkinson Disease (Parkinson's Disease)
01/2020 - 11/2018
2Schizophrenia (Dementia Praecox)
05/2019 - 01/2018
1Body Weight (Weight, Body)
05/2022
1Neuralgia (Stump Neuralgia)
10/2021
1Chronic Pain
10/2021
1Type 2 Diabetes Mellitus (MODY)
07/2021
1Mood Disorders (Mood Disorder)
05/2019
1Cardiovascular Diseases (Cardiovascular Disease)
04/2017
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2017
1Abdominal Obesity
04/2017
1Corneal Injuries
06/2013
1Corneal Neovascularization
06/2013

Drug/Important Bio-Agent (IBA)

4Insulin (Novolin)FDA Link
07/2021 - 04/2015
3Glucose (Dextrose)FDA LinkGeneric
05/2022 - 04/2015
2Sucrose (Saccharose)IBA
05/2022 - 04/2015
2AdipokinesIBA
05/2022 - 04/2017
2LeptinIBA
05/2022 - 04/2017
2Triglycerides (Triacylglycerol)IBA
07/2021 - 04/2015
2Streptozocin (Streptozotocin)FDA Link
06/2021 - 01/2020
2Serine (L-Serine)FDA Link
08/2020 - 01/2018
2Monoamine Oxidase (MAO)IBA
01/2020 - 11/2018
2Antidepressive Agents (Antidepressants)IBA
01/2020 - 11/2018
2Dopamine (Intropin)FDA LinkGeneric
05/2019 - 11/2018
2Amine Oxidase (Copper-Containing)IBA
04/2017 - 06/2013
2Proteins (Proteins, Gene)FDA Link
04/2015 - 06/2013
1KisspeptinsIBA
05/2022
1CytokinesIBA
05/2022
1AdiponectinIBA
05/2022
1AngiotensinsIBA
10/2021
1Opioid Analgesics (Opioids)IBA
10/2021
1Analgesics (Analgesic Drugs)IBA
10/2021
1Opioid Receptors (Opioid Receptor)IBA
10/2021
1LigandsIBA
10/2021
1Angiotensin Receptors (Angiotensin II Receptor)IBA
10/2021
1AminesIBA
07/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
07/2021
1Uric Acid (Urate)IBA
07/2021
1Glycogen Synthase Kinase 3IBA
06/2021
1Exenatide (Byetta)FDA Link
06/2021
1TeaIBA
10/2020
1Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
01/2020
1Protective AgentsIBA
01/2020
1Levodopa (L Dopa)FDA LinkGeneric
01/2020
1Antipsychotic Agents (Antipsychotics)IBA
05/2019
1Selegiline (E250)FDA LinkGeneric
11/2018
1Neuroprotective AgentsIBA
11/2018
1ElementsIBA
11/2018
1rasagiline (Azilect)FDA Link
11/2018
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2018
1D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA
01/2018
1LipidsIBA
04/2017
1C-Reactive ProteinIBA
04/2017
1Biomarkers (Surrogate Marker)IBA
04/2017
1Receptor for Advanced Glycation End ProductsIBA
04/2017
1AntioxidantsIBA
04/2015
1Thiobarbituric Acid Reactive SubstancesIBA
04/2015
1Drinking WaterIBA
04/2015
1FructoseIBA
04/2015
1human AOC3 proteinIBA
06/2013
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
06/2013
1N'-(2-phenylallyl)hydrazineIBA
06/2013

Therapy/Procedure

2Therapeutics
11/2018 - 06/2013
1Ligation
03/2021